title: Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis.
authors.affiliation: a Department of Paediatrics and Neonatology , Asklepios Clinics , Sankt Augustin , Germany.
authors.forename: G
authors.initials: G
authors.lastname: Horneff
authors.affiliation: a Department of Paediatrics and Neonatology , Asklepios Clinics , Sankt Augustin , Germany.
authors.forename: J
authors.initials: J
authors.lastname: Peitz
authors.affiliation: b HELIOS Specialist Clinic , Vogelsang-Gommern , Gommern , Germany.
authors.forename: J
authors.initials: J
authors.lastname: Kekow
authors.affiliation: c Department of Paediatric Rheumatology and Immunology , University of Muenster , Münster , Germany.
authors.forename: D
authors.initials: D
authors.lastname: Foell
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D001171:Arthritis, Juvenile / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D015415:Biomarkers / Q000097:blood; D040501:Calgranulin A / Q000097:blood*; D040502:Calgranulin B / Q000097:blood*; D002675:Child, Preschool; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D020382:Interleukin-18 / Q000097:blood*; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors; D008262:Macrophage Activation; D008297:Male; D016896:Treatment Outcome
chemical_list: D000209:Acute-Phase Proteins; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D040501:Calgranulin A; D040502:Calgranulin B; D007155:Immunologic Factors; D020382:Interleukin-18; D053583:Interleukin-1beta; C541220:canakinumab